This inventor holds 30 USPTO granted patents and 8 published patent applications and 1 EPO patent, primarily in Antimicrobial Peptides. Top assignees: University of Colorado, Pence, Inc., University of Alberta. Active years: 1993-2020.
Location History:
- Saginaw, MI (US) (1997)
- Edmonton, CA (1993 - 2007)
- Denver, CO (US) (2011 - 2017)
- Aurora, CO (US) (2019 - 2020)
Company Filing History:
12 out of 1,447 
5 out of 5 
5 out of 454 
Years Active: 1993-2020
Areas of Expertise:
Title: **Innovations and Contributions of Robert S. Hodges in Antimicrobial Peptides**
Introduction
Robert S. Hodges is a notable inventor based in Denver, Colorado, recognized for his extensive contributions to the field of antimicrobial peptides. With a remarkable portfolio of 30 patents, his work focuses on innovative techniques and compositions for treating gram-negative pathogens, significantly advancing microbial treatment methodologies.
Latest Patents
Among his latest patents, Robert Hodges has developed several key innovations. One of his significant patents involves antimicrobial peptides and methods for treating gram-negative pathogens, offering unique polar and non-polar face analogs. These antimicrobial agents demonstrate high efficacy against bacterial pathogens while effectively reducing hemolytic activity against human red blood cells. His work with dermaseptin-type and piscidin-type antimicrobial peptide variants highlights his dedication to creating compositions that not only maintain but improve antimicrobial activity against diverse microbial threats, optimizing therapeutic indices as well.
Career Highlights
Robert's career includes pivotal roles at the University of Colorado and Pence, Inc., where he has contributed to groundbreaking research and innovations. His extensive experience and ingenuity have allowed him to develop valuable patents that bridge the gap between scientific research and practical application in the medical field.
Collaborations
Throughout his career, Robert has collaborated with esteemed colleagues such as Randall Thomas Irvin and R. Bruce Lennox. These partnerships have fostered an environment of innovation and knowledge sharing, leading to the development of effective antimicrobial solutions.
Conclusion
Robert S. Hodges continues to be a driving force in the field of antimicrobial research, with his patents playing a crucial role in the fight against harmful pathogens. His contributions to the medical and scientific communities underscore the importance of innovation in developing effective treatment methods that can ultimately save lives.